TIDES Europe: Oligonucleotide and Peptide Therapeutics 2026

TIDES Europe 2026, held 3‑5 November at the RAI Amsterdam Convention Centre, is Europe’s leading conference for oligonucleotide and peptide therapeutics. The program spans six scientific tracks: Oligonucleotide Chemistry & CMC, Oligonucleotide Discovery, Peptide Chemistry & CMC, Peptide Discovery, mRNA Therapeutics & Genome Editing, and Macromolecular Drug Delivery. Over 90 exhibitors showcase technologies for nucleic‑acid synthesis, peptide engineering, delivery platforms, analytical tools, and regulatory support. Attendees can access case‑study presentations, digital innovation workshops, and interactive sessions on topics such as obesity‑targeting oligos, antibody‑oligonucleotide conjugates, and antibody‑peptide conjugates. The event draws >900 industry professionals, including R&D scientists, CMC specialists, regulatory affairs experts, and business development leaders, offering networking, one‑to‑one meetings, and sponsorship opportunities to accelerate therapeutic development from discovery to market.

---

Register for entry or booths

---

Venue Map and Hotels Around

Amsterdam - RAI Amsterdam, North Holland, Netherlands